AIM2 and neoplasm: Furthermore, the rescued malignant behaviours including tumour volume and tumour weight were observed in YVAD‐CMK‐treated Ad‐CAIXpromotor‐AIM2 group compared with Ad‐CAIXpromotor‐AIM2 group (Figure 5C‐E).